Verastem
2 known investors
Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients. The company focuses on oncology therapeutics including small molecules and monoclonal antibodies targeting pathways such as RAS, KRAS, and immune modulation.
BiotechMedical Devices
Founders & leadership
RW
Robert Weinberg
Investors · 2
In the news
- Here’s What RBC Capital Has to Say About Verastem (VSTM) - Insider Monkeyinsidermonkey.com · 2026
- Verastem stock price target maintained at $18 by BTIG on trial data By Investing.cominvesting.com · 2026
- Verastem raises fresh capital, shares trade in biotech spotlight on Nasdaqad-hoc-news.de · 2026